China Journal of Leprosy and Skin Diseases ›› 2023, Vol. 39 ›› Issue (12): 898-900.doi: 10.12144/zgmfskin202312898

• Case Reports • Previous Articles     Next Articles

Rituximab in the treatment of systemic lupus erythematosus with blood crisis: a case report

LONG Boquan1,2, YANG Lan1,3, MA Pingping2, LAI Huijun1,3, DOU Shuhui2, CAI Chuanchuan2, GUO Hongwei1, LI Ding2   

  1. 1 Dermatological Department of The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang 524003, China;2 Dermatological Department of The Affiliated Hospital of Guangdong Medical University, Zhanjiang 524000, China;3 Guangdong Medical University, Zhanjiang 524003, China
  • Online:2023-12-15 Published:2023-11-22

Abstract: We report a case of systemic lupus erythematosus patient with progressive cytopenia, fever, fatigue, and nasal mucosal bleeding. Methylprednisolone was gradually increased from the standard dose to 500 mg/d (combined with gamma globulin). The patient's condition improved, but neuropsychiatric symptoms and other adverse reactions occurred. Two days later, the patient's condition recurred with a small amount of bleeding from the nasal mucosa. The patient was improved after the addition of rituximab, and his condition was stable after two and a half years follow up.

Key words: systemic lupus erythematosus, blood crisis, rituximab treatment